EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular Mechanisms of ARD1 in Tumors

Chunjiao Yu iD, Hongtao Lei, Xuefei Hou, Shan Yan

Cancer Medicine · 2025

DOI: 10.1002/cam4.70708 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Medicine, 2025. Verfasst von Chunjiao Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Engineering, Kunming Medical University, Chenggong District, Kunming, Yunnan, People's Republic of China. Hauptthemen laut MEDLINE: Neoplasms, N-Terminal Acetyltransferase E. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Arrest‐deficient protein 1 (ARD1) is an acetyltransferase that acetylates the N‐terminal amino acids and internal lysine residues of proteins. It plays a crucial role in various cellular processes. The significance of ARD1 in tumor development has become increasingly evident in recent years.

Methods

This review analyzes the regulatory role of ARD1 in tumor progression by examining its involvement in processes such as cell cycle regulation, cell proliferation, metastasis, apoptosis, and autophagy. Additionally, we discuss the expression patterns and molecular mechanisms of ARD1 in different types of cancer.

Results

Elevated levels of ARD1 have been reported in several cancer types. Its increased expression is associated with various tumor characteristics, suggesting it may serve as a potential prognostic biomarker. Furthermore, ARD1 could be targeted for the development of novel cancer therapies.

Conclusion

Understanding the role of ARD1 in tumor biology provides valuable insights into potential therapeutic targets and biomarkers for cancer treatment. This review highlights the advances in ARD1‐related research and suggests that it may be a promising avenue for improving cancer prognosis and treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsN-Terminal Acetyltransferase EHumansBiomarkers, TumorPrognosisAutophagyCell ProliferationGene Expression Regulation, NeoplasticApoptosisAnimalsN-Terminal Acetyltransferase A

Stichwörter der Autor:innen

ARD1acetylationtumor

Substanzen

N-Terminal Acetyltransferase EBiomarkers, TumorNAA10 protein, humanN-Terminal Acetyltransferase A

Autor:innen und Institutionen

  • Institute of Biomedical Engineering, Kunming Medical University, Chenggong District, Kunming, Yunnan, People's Republic of China.
  • Yunnan Key Laboratory of Breast Cancer Precision Medicine, Chenggong District, Kunming, Yunnan, People's Republic of China.

ORCID-Profile: Chunjiao Yu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yu, C., Lei, H., Hou, X., & Yan, S. (2025). Molecular Mechanisms of ARD1 in Tumors. Cancer Medicine. https://doi.org/10.1002/cam4.70708

Vancouver

Yu C, Lei H, Hou X, Yan S. Molecular Mechanisms of ARD1 in Tumors. Cancer Medicine. 2025. doi:10.1002/cam4.70708

BibTeX
@article{Yu2025,
  author = {Yu, Chunjiao and Lei, Hongtao and Hou, Xuefei and Yan, Shan},
  title = {Molecular Mechanisms of ARD1 in Tumors},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.70708}
}
Kostenlos starten →